# TriSalus Life Sciences, Inc.: Form SCHEDULE 13D/A, filed May 2, 2025

- Company: [TriSalus Life Sciences, Inc.](/companies/tlsi.md) (CIK 1826667)
- Form: SCHEDULE 13D/A
- Filed: 2025-05-02
- Accepted by EDGAR: May 2, 2025, 20:17 ET
- Period: not reported
- Accession: 0001415889-25-011783
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1826667/000141588925011783/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1826667/000141588925011783/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1826667/000141588925011783/xslSCHEDULE_13D_X01/primary_doc.xml

Filed May 2, 2025.
Source: SEC EDGAR, the filing index for accession 0001415889-25-011783. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.